Envista (NYSE:NVST) Upgraded at Mizuho

Mizuho upgraded shares of Envista (NYSE:NVST) from a strong sell rating to a hold rating in a research report sent to investors on Tuesday, MarketBeat reports. The firm currently has $24.00 price target on the stock, up from their prior price target of $19.00.

NVST has been the topic of several other research reports. JPMorgan Chase & Co. raised their price objective on Envista from $20.00 to $22.00 and gave the stock a “neutral” rating in a report on Tuesday, December 16th. Wall Street Zen lowered Envista from a “strong-buy” rating to a “buy” rating in a research note on Sunday, January 18th. Evercore ISI reaffirmed an “outperform” rating on shares of Envista in a research note on Friday, October 31st. Robert W. Baird set a $27.00 price objective on shares of Envista in a report on Friday, October 31st. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Envista in a research report on Monday, December 29th. Five analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $22.17.

Envista Stock Performance

Shares of NYSE NVST opened at $24.40 on Tuesday. The company has a 50-day simple moving average of $21.86 and a 200-day simple moving average of $20.90. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.37 and a quick ratio of 2.02. The company has a market cap of $4.01 billion, a PE ratio of 271.14, a price-to-earnings-growth ratio of 1.10 and a beta of 0.99. Envista has a 12 month low of $14.22 and a 12 month high of $25.41.

Envista (NYSE:NVST) last announced its quarterly earnings data on Wednesday, October 29th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.05. The business had revenue of $669.90 million for the quarter, compared to the consensus estimate of $639.49 million. Envista had a net margin of 0.58% and a return on equity of 5.90%. The company’s quarterly revenue was up 11.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.12 earnings per share. On average, equities analysts anticipate that Envista will post 1 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Farther Finance Advisors LLC increased its position in shares of Envista by 317.6% in the third quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company’s stock worth $27,000 after acquiring an additional 1,026 shares in the last quarter. Caitong International Asset Management Co. Ltd lifted its holdings in shares of Envista by 16,711.1% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after acquiring an additional 1,504 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Envista by 73.1% during the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock worth $44,000 after purchasing an additional 949 shares during the period. EverSource Wealth Advisors LLC increased its holdings in Envista by 378.0% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company’s stock valued at $47,000 after purchasing an additional 1,909 shares in the last quarter. Finally, SJS Investment Consulting Inc. increased its holdings in Envista by 10,356.5% in the 3rd quarter. SJS Investment Consulting Inc. now owns 2,405 shares of the company’s stock valued at $49,000 after purchasing an additional 2,382 shares in the last quarter.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.